The Supreme Court denied the plaintiffs’ Petition for a Writ of Certiorari in Clayworth v. Pfizer, Inc., et al., in which the plaintiffs sought Supreme Court review of a California state antitrust action in which the plaintiffs accused fifteen pharma companies and their trade association of conspiring to fix prices in violation of the Cartwright Act, California’s antitrust statute, by using Canadian drug prices as a floor and preventing cross-border importation. The rejection ended nine years of litigation, upholding a 2012 decision by the California Court of Appeal that affirmed a 2011 grand of summary judgment in favor of the defendants.
Kaye Scholer’s Antitrust Practice Group Co-Chair Saul P. Morgenstern argued summary judgment in the trial court on behalf of the moving defendants, and Los Angeles based partner Aton Arbisser argued in the California Court of Appeal. The litigation team included Bryant Delgadillo (LA counsel), Karin E. Garvey (NY counsel), Amanda Myers (LA Associate) and Michael Schenk (LA paralegal).
Also of Interest
- NLJ Names Shores as Antitrust Trailblazer September 27, 2016 • Recognitions
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes
- Kaye Scholer Advises Veracen on Merger of Equals with Turner Investments August 31, 2016 • Client Successes
- Doing Deals with Competitors: Beware of Taking Minority Equity Stakes or Board Seats August 24, 2016 • Articles
- Kaye Scholer Represents Lonza in Acquisition of InterHealth Nutraceuticals August 16, 2016 • Client Successes
- Best Lawyers 2017 Recognizes 41 Kaye Scholer Lawyers August 15, 2016 • Recognitions
- 3D Printing: New Life Sciences Technology and Old Product Liability Claims August 1, 2016 • Articles